Tokyo, Dec. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059956) titled 'Retrospective study of treatment outcomes and safety of preoperative chemotherapy for resectable esophageal cancer' on Dec. 10.
Study Type:
Observational
Primary Sponsor:
Institute - University of toyama
Condition:
Condition - Esophageal cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Esophageal cancer is the sixth leading cause of cancer death worldwide, and the 5-year survival rate for advanced esophageal cancer is poor, at 15%. The standard neoadjuvant treatment for resectable advanced esophageal cancer has been 5-FU plus cisplatin (FP therapy). Howe...